美国胸外科协会关于二叶式主动脉瓣相关主动脉病变的共识指南:执行摘要
二叶式主动脉瓣疾病在普通人群中占1%至2%,约40%的转诊中心患者存在胸主动脉扩张。该执行摘要汇总了美国胸外科协会指南中关于自然病史、表型表达、组织学与分子病理机制、影像学、手术指征、监测随访及未来研究建议等主要内容,为临床医生提供综合回顾并指导日常管理。
要点
- 二叶式主动脉瓣疾病在普通人群中占1%至2%。
- 约40%的转诊中心二叶式主动脉瓣疾病患者存在胸主动脉扩张。
- 该执行摘要涵盖自然病史、表型、组织学与分子机制、影像、手术指征、监测随访及未来研究建议。
核心结论
- 该执行摘要为临床医生提供关于二叶式主动脉瓣相关主动脉病变的当前综合回顾,并指导这类复杂患者的日常管理。
研究设计与样本
- 美国胸外科协会制定共识指南,本文为其执行摘要。
主要发现
- 二叶式主动脉瓣疾病在普通人群中占1%至2%。
- 约40%的转诊中心二叶式主动脉瓣疾病患者存在胸主动脉扩张。
- 既往已有若干共识声明和指南涉及二叶式主动脉瓣相关主动脉病变的管理,但均未完全聚焦于该疾病过程。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bicuspid aortic valve disease is a common congenital cardiac disorder, being present in 1% to 2% of the general population. Associated aortopathy is a common finding in patients with bicuspid aortic valve disease, with thoracic aortic dilation noted in approximately 40% of patients in referral centers. Several previous consensus statements and guidelines have addressed the management of bicuspid aortic valve-associated aortopathy, but none focused entirely on this disease process. The current document is an executive summary of "The American Association for Thoracic Surgery Guidelines on Bicuspid Aortic Valve-Related Aortopathy." All major aspects of bicuspid aortic valve aortopathy, including natural history, phenotypic expression, histology and molecular pathomechanisms, imaging, indications for surgery, surveillance, and follow-up, and recommendations for future research are contained within these guidelines. The current executive summary serves as a condensed version of the guidelines to provide clinicians with a current and comprehensive review of bicuspid aortic valve aortopathy and to guide the daily management of these complex patients.
引用
- Borger MA, Fedak PWM, Stephens EH, et al. The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Executive summary. J Thorac Cardiovasc Surg. 2018. PMID: 30011756. doi:10.1016/j.jtcvs.2017.10.161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。